Cardiac Amyloidosis No longer uncommon and untreatable – Bell-Ezziddine

Guest: Omar F. Abou Ezzeddine, M.D., M.S.
Hosts: Malcolm R. Bell, M.D.
 
Transthyretin amyloid cardiomyopathy (ATTR-CM), as soon as thought of uncommon, is extra prevalent than beforehand thought. Diagnosing ATTR-CM is especially necessary as a result of there at the moment are extremely efficient, particular therapies for ATTR-CM. In this podcast, we are going to present a recent evaluation of the diagnostic and therapeutic method to sufferers with ATTR-CM within the present period.
 
Topics Discussed:

• When to suspect the illness & who to display for ATTR-CM?
• How to diagnose and prognosticate ATTR-CM within the present period?
• Provide an outline of present and rising therapies for managing ATTR-CM.

Connect with Mayo Clinic’s Cardiovascular Continuing Medical Education on-line at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services

Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an revolutionary academic platform that options cardiology-focused persevering with medical schooling wherever and everytime you want it. Use this app to entry different free content material and browse upcoming programs. Download it free of charge in Apple or Google shops at present!

No CME credit score supplied for this episode.